search
Back to results

LIFUP for Treatment of Motor Deficits in Parkinson's Disease (LIFUP)

Primary Purpose

Parkinson Disease

Status
Recruiting
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Active LIFUP Treatment
Sham LIFUP Treatment
Sponsored by
University of California, Los Angeles
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Parkinson Disease focused on measuring LIFUP, Ultrasound

Eligibility Criteria

18 Years - 65 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: Diagnosis of Parkinson's disease Age 18-65 Right-handed Fluent in the English language Exclusion Criteria: Metal implants Neurological or psychiatric diagnosis other than Parkinson's Left-handed Not fluent in the English language

Sites / Locations

  • University of California, Los AngelesRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Sham Comparator

Arm Label

Low Intensity Focused Ultrasound

Control

Arm Description

Device: Low Intensity Focused Ultrasound Device Low Intensity Focused Ultrasound Pulsation (LIFUP) of putamen (a key area for Parkinson's disease) will be performed during two sessions. The proposed experiment will involve behavioral (e.g., motor assessements) and paramedical (i.e., MRI/fMRI) measurements just before and after each of two LIFUP sessions (i.e., 5 non-consecutive minutes of stimulation in each session). The device does not produce a sound when operating and as such, the active group is well blinded.

Sham Treatment consists of placing the device but not turning it on. The device does not produce a sound when operating and as such, the sham group is well blinded.

Outcomes

Primary Outcome Measures

Motor Assessment 1: Finger Tapping
The participant will use their index and thumb fingers to tap rhythmically, alternating index finger and thumb. Analysis will compare the average frequency, velocity, and amplitude of taps to quantify motor performance improvements.
Motor Assessment 2: 9-Hole Pegboard Dexterity Test
The participant will place and remove nine plastic pegs into a plastic pegboard. Scores are recorded as time in seconds that it takes the participant to complete the task with each hand. Analysis will compare pre- and post-treatment scores to quantify motor performance improvements.
Motor Assessment 3: Unified Parkinson Disease Rating Scale (UPDRS)
The participant will answer 45 survey questions that characterize PD severity across four domains. Analysis will compare ratings pre- and post-treatment to assess changes in 1) mentation, behavior, and mood, 2) activity of daily living, 3) motor function, and 4) complications of therapy.
MRI Task: Implicit Learning Paradigm
In the MRI scanner, the participant will play an experimental task designed to investigate implicit learning in PD. The paradigm will be assessed by feedback-based probabilistic classification. Analysis will compare within-subject scores between session 1 and 2 to quantify LIFUP-mediated gains in performance.

Secondary Outcome Measures

BOLD fMRI Signal in Putamen
BOLD data will be collected in real-time during the ultrasound sonication, which occurs in on-off blocks. Analyses will assess the statistical relationship between BOLD signal in the brain and the time series (on vs off) of the ultrasound sonication.
Perfusion ASL fMRI Signal throughout Brain
Perfusion ASL fMRI data will be collected before and after sonication. Analyses will assess the statistical relationship between ASL signal throughout the brain pre- and post-sonication in a within-subject repeated measures design.

Full Information

First Posted
October 3, 2020
Last Updated
July 12, 2023
Sponsor
University of California, Los Angeles
search

1. Study Identification

Unique Protocol Identification Number
NCT04593875
Brief Title
LIFUP for Treatment of Motor Deficits in Parkinson's Disease
Acronym
LIFUP
Official Title
Low-Intensity Focused Ultrasound Pulsation for Treatment of Motor Deficits in Parkinson's Disease
Study Type
Interventional

2. Study Status

Record Verification Date
July 2023
Overall Recruitment Status
Recruiting
Study Start Date
June 15, 2022 (Actual)
Primary Completion Date
November 2023 (Anticipated)
Study Completion Date
November 2023 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of California, Los Angeles

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
Yes
Device Product Not Approved or Cleared by U.S. FDA
Yes
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The study will test the feasibility of using Low Intensity Focused Ultrasound Pulsation (LIFUP) to treat motor symptoms in Parkinson's Disease (PD). LIFUP is a new technique that can increase brain activity in highly specific target areas and is MRI compatible. Thus, in real-time, it is possible to directly observe how LIFUP changes the brain areas important in PD by measuring its effects on brain activity, blood flow, and brain connectivity. If successful, this research will mark the first step towards a novel, non-invasive, non-medication treatment for PD.
Detailed Description
This trial is a proof-of-context, proof-of-mechanism study of a novel neuromodulation technology - LIFUP - to treat motor symptoms in PD. Much like Deep Brain Stimulation, LIFUP can be focused on deep brain structures with high spatial accuracy, including those implicated in PD; however, it can do so non-invasively. Other non-invasive neuromodulation tools such as Transcranial Magnetic Stimulation can only target surface brain structures and are not optimal PD treatment tools. This study will test this new technology in 30 participants with PD during simultaneous MRI (including resting-state functional MRI (fMRI), task-based fMRI, and arterial spin labeling (ASL) perfusion) in a double-blind crossover trial to determine whether LIFUP: 1) will improve motor symptoms during and after treatment; 2) can increase neural activity in the target brain region important for PD, the Putamen; and 3) enhance cortico-striatal motor circuit connectivity.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Parkinson Disease
Keywords
LIFUP, Ultrasound

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantOutcomes Assessor
Allocation
Randomized
Enrollment
30 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Low Intensity Focused Ultrasound
Arm Type
Experimental
Arm Description
Device: Low Intensity Focused Ultrasound Device Low Intensity Focused Ultrasound Pulsation (LIFUP) of putamen (a key area for Parkinson's disease) will be performed during two sessions. The proposed experiment will involve behavioral (e.g., motor assessements) and paramedical (i.e., MRI/fMRI) measurements just before and after each of two LIFUP sessions (i.e., 5 non-consecutive minutes of stimulation in each session). The device does not produce a sound when operating and as such, the active group is well blinded.
Arm Title
Control
Arm Type
Sham Comparator
Arm Description
Sham Treatment consists of placing the device but not turning it on. The device does not produce a sound when operating and as such, the sham group is well blinded.
Intervention Type
Device
Intervention Name(s)
Active LIFUP Treatment
Other Intervention Name(s)
BX Pulsar 1002
Intervention Description
2 LIFUP Treatments
Intervention Type
Device
Intervention Name(s)
Sham LIFUP Treatment
Intervention Description
2 sham LIFUP treatments
Primary Outcome Measure Information:
Title
Motor Assessment 1: Finger Tapping
Description
The participant will use their index and thumb fingers to tap rhythmically, alternating index finger and thumb. Analysis will compare the average frequency, velocity, and amplitude of taps to quantify motor performance improvements.
Time Frame
Change from Baseline Finger Tapping at 2 weeks
Title
Motor Assessment 2: 9-Hole Pegboard Dexterity Test
Description
The participant will place and remove nine plastic pegs into a plastic pegboard. Scores are recorded as time in seconds that it takes the participant to complete the task with each hand. Analysis will compare pre- and post-treatment scores to quantify motor performance improvements.
Time Frame
Change from Baseline Dexterity at 2 weeks
Title
Motor Assessment 3: Unified Parkinson Disease Rating Scale (UPDRS)
Description
The participant will answer 45 survey questions that characterize PD severity across four domains. Analysis will compare ratings pre- and post-treatment to assess changes in 1) mentation, behavior, and mood, 2) activity of daily living, 3) motor function, and 4) complications of therapy.
Time Frame
Change from Baseline UPDRS at 2 weeks
Title
MRI Task: Implicit Learning Paradigm
Description
In the MRI scanner, the participant will play an experimental task designed to investigate implicit learning in PD. The paradigm will be assessed by feedback-based probabilistic classification. Analysis will compare within-subject scores between session 1 and 2 to quantify LIFUP-mediated gains in performance.
Time Frame
Change from Baseline at 2 weeks
Secondary Outcome Measure Information:
Title
BOLD fMRI Signal in Putamen
Description
BOLD data will be collected in real-time during the ultrasound sonication, which occurs in on-off blocks. Analyses will assess the statistical relationship between BOLD signal in the brain and the time series (on vs off) of the ultrasound sonication.
Time Frame
Change from Baseline at 2 weeks
Title
Perfusion ASL fMRI Signal throughout Brain
Description
Perfusion ASL fMRI data will be collected before and after sonication. Analyses will assess the statistical relationship between ASL signal throughout the brain pre- and post-sonication in a within-subject repeated measures design.
Time Frame
Change from Baseline at 2 weeks

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Diagnosis of Parkinson's disease Age 18-65 Right-handed Fluent in the English language Exclusion Criteria: Metal implants Neurological or psychiatric diagnosis other than Parkinson's Left-handed Not fluent in the English language
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Taylor P Kuhn, Ph.D.
Phone
310-825-2631
Email
tkuhn@mednet.ucla.edu
First Name & Middle Initial & Last Name or Official Title & Degree
Bianca H Dang
Phone
3107940077
Email
tfus@mednet.ucla.edu
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Taylor P Kuhn, Ph.D.
Organizational Affiliation
University of California, Los Angeles
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of California, Los Angeles
City
Los Angeles
State/Province
California
ZIP/Postal Code
90095
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Bianca H Dang
Phone
310-794-0077
Email
tfus@mednet.ucla.edu
First Name & Middle Initial & Last Name & Degree
Natalie M Rotstein
Phone
310-794-0077
Email
tfus@mednet.ucla.edu
First Name & Middle Initial & Last Name & Degree
Taylor P Kuhn, PhD
First Name & Middle Initial & Last Name & Degree
Susan Y Bookheimer, PhD
First Name & Middle Initial & Last Name & Degree
Jeff M Bronstein, MD, PhD

12. IPD Sharing Statement

Plan to Share IPD
Undecided

Learn more about this trial

LIFUP for Treatment of Motor Deficits in Parkinson's Disease

We'll reach out to this number within 24 hrs